Avalon Trust CO Novartis Ag Transaction History
Avalon Trust CO
- $1.37 Trillion
- Q2 2025
A detailed history of Avalon Trust CO transactions in Novartis Ag stock. As of the latest transaction made, Avalon Trust CO holds 1,233 shares of NVS stock, worth $161,239. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,233
Previous 1,500
17.8%
Holding current value
$161,239
Previous $167 Million
10.77%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding NVS
# of Institutions
1,561Shares Held
136MCall Options Held
1.72MPut Options Held
1.7M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.36 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.18 Billion0.26% of portfolio
-
Morgan Stanley New York, NY7.56MShares$989 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$931 Million0.35% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $281B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...